In this study, we describe a novel murine model of chronic intestinal
inflammation induced by the
hapten reagent 2,4,6-trinitrobenzene sulfonic acid (TNBS). Rectal application of low doses of TNBS in BALB/c and SJL/J mice resulted in a chronic transmural
colitis with severe
diarrhea,
weight loss, and
rectal prolapse, an illness that mimics some characteristics of
Crohn's disease in humans. The colon of TNBS-treated mice on day 7 was marked by infiltration of CD4+ T cells; furthermore, in situ polymerase chain reaction studies revealed high levels of
interferon (IFN)-gamma
mRNA in diseased colons. Isolated lamina propria (LP) CD4+ T cells from TNBS-treated mice stimulated with anti-CD3 and anti-CD28
antibodies exhibited a Th1 pattern of
cytokine secretion: a 20-50-fold increase in
IL-2 and IFN-gamma levels and a 5-fold decrease in
IL-4 levels as compared with those of stimulated LP CD4+ T cells from control BALB/c mice. Administration of monoclonal anti-IL-12
antibodies to the TNBS-treated mice both early (at 5 d) and late (at 20 d) after induction of
colitis led to a striking improvement in both the clinical and histopathological aspects of the disease and frequently abrogated the established
colitis completely. Furthermore, LP CD4+ T cells isolated from anti-IL-12-treated mice failed to secrete IFN-gamma upon in vitro stimulation. In summary, the data demonstrate the pivotal role of
IL-12 and IFN-gamma in a TNBS-induced murine model of chronic intestinal
inflammation. Furthermore, they suggest the potential utility of anti-IL-12
antibodies in patients with
Crohn's disease.